DK154424C - Analogifremgangsmaade til fremstilling af acylderivater af carnitin - Google Patents

Analogifremgangsmaade til fremstilling af acylderivater af carnitin

Info

Publication number
DK154424C
DK154424C DK100181A DK100181A DK154424C DK 154424 C DK154424 C DK 154424C DK 100181 A DK100181 A DK 100181A DK 100181 A DK100181 A DK 100181A DK 154424 C DK154424 C DK 154424C
Authority
DK
Denmark
Prior art keywords
acyly
carnitin
analogy
derivatives
preparation
Prior art date
Application number
DK100181A
Other languages
Danish (da)
English (en)
Other versions
DK154424B (da
DK100181A (da
Inventor
Claudio Cavazza
Paolo De Witt
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of DK100181A publication Critical patent/DK100181A/da
Publication of DK154424B publication Critical patent/DK154424B/da
Application granted granted Critical
Publication of DK154424C publication Critical patent/DK154424C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK100181A 1980-03-06 1981-03-05 Analogifremgangsmaade til fremstilling af acylderivater af carnitin DK154424C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48099/80A IT1145362B (it) 1980-03-06 1980-03-06 Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
IT4809980 1980-03-06

Publications (3)

Publication Number Publication Date
DK100181A DK100181A (da) 1981-09-07
DK154424B DK154424B (da) 1988-11-14
DK154424C true DK154424C (da) 1989-05-22

Family

ID=11264505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100181A DK154424C (da) 1980-03-06 1981-03-05 Analogifremgangsmaade til fremstilling af acylderivater af carnitin

Country Status (22)

Country Link
US (2) US4766222A (fi)
JP (1) JPS56139442A (fi)
AR (1) AR228591A1 (fi)
AT (1) AT376200B (fi)
AU (1) AU543799B2 (fi)
BE (1) BE887695A (fi)
CA (1) CA1178971A (fi)
CH (1) CH653008A5 (fi)
DE (1) DE3107743A1 (fi)
DK (1) DK154424C (fi)
ES (1) ES500131A0 (fi)
FI (1) FI78680C (fi)
FR (1) FR2477536B1 (fi)
GB (1) GB2071091B (fi)
GR (1) GR74440B (fi)
IE (1) IE50959B1 (fi)
IL (1) IL62189A (fi)
IT (1) IT1145362B (fi)
LU (1) LU83183A1 (fi)
MX (1) MX155928A (fi)
NL (1) NL8101067A (fi)
SE (1) SE452004B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
WO2001032168A1 (en) 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
CA2561733A1 (en) * 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
JP6296433B2 (ja) * 2012-11-22 2018-03-20 国立大学法人山形大学 生体適合性ポリマー及びその製造方法並びにそれを製造するための新規化合物
US11103588B2 (en) 2017-06-06 2021-08-31 Wayne State University Methods and compositions relating to carnitine-derived materials

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1108125A (fr) * 1953-05-08 1956-01-09 Laboratoires Labaz Soc D Procédé de préparation d'un dérivé stable de la carnitine
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
JPS5481963A (en) * 1977-12-13 1979-06-29 Ihachi Nosaka Roll paper holder for lavatory
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
JPS5554821A (en) * 1978-10-18 1980-04-22 Iseki Agricult Mach Discharging dust adjuster of thresher
US4518776A (en) * 1982-07-19 1985-05-21 Ciba Geigy Corporation Process for producing sulfonylureas
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US4707491A (en) * 1985-12-20 1987-11-17 Washington University Anticonvulsant γ-thiobutyrolactone derivatives

Also Published As

Publication number Publication date
JPS56139442A (en) 1981-10-30
IL62189A0 (en) 1981-03-31
IT1145362B (it) 1986-11-05
ES8201535A1 (es) 1982-01-01
AT376200B (de) 1984-10-25
LU83183A1 (fr) 1981-06-24
AU6802881A (en) 1981-09-24
IE50959B1 (en) 1986-08-20
FI810695L (fi) 1981-09-07
GB2071091A (en) 1981-09-16
GB2071091B (en) 1984-09-12
ES500131A0 (es) 1982-01-01
FI78680B (fi) 1989-05-31
AU543799B2 (en) 1985-05-02
US4766222A (en) 1988-08-23
SE452004B (sv) 1987-11-09
SE8101267L (sv) 1981-09-07
IT8048099A0 (it) 1980-03-06
GR74440B (fi) 1984-06-28
CH653008A5 (it) 1985-12-13
FR2477536A1 (fr) 1981-09-11
IL62189A (en) 1985-10-31
IE810359L (en) 1981-09-06
US4859698A (en) 1989-08-22
ATA103981A (de) 1984-03-15
BE887695A (fr) 1981-06-15
CA1178971A (en) 1984-12-04
DK154424B (da) 1988-11-14
FR2477536B1 (fr) 1986-04-04
DE3107743A1 (de) 1981-12-03
FI78680C (fi) 1989-09-11
DK100181A (da) 1981-09-07
AR228591A1 (es) 1983-03-30
NL8101067A (nl) 1981-10-01
MX155928A (es) 1988-05-24

Similar Documents

Publication Publication Date Title
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK155282C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK158788C (da) Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK534481A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK157680C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK148300C (da) Analogifremgangsmaade til fremstilling af acylderivater af carnitin
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
DK157920C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK157995C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK162167C (da) Analogifremgangsmaade til fremstilling af mitosanderivater
DK154424C (da) Analogifremgangsmaade til fremstilling af acylderivater af carnitin
DK151256C (da) Analogifremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK161310C (da) Analogifremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK152674C (da) Analogifremgangsmaade til fremstilling af 3-metyltiometyl-4-oxo-quinolonderivater
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK156219C (da) Analogifremgangsmaade til fremstilling af spirothiazolidinylpiperazinderivater

Legal Events

Date Code Title Description
PUP Patent expired